GW enters corporate partnership on cancer research
GW has entered into a $3.2 million corporate research agreement with a medical company to develop devices for cancer therapies.
Stories from the November 19, 2020 issue of the GW Hatchet.
GW has entered into a $3.2 million corporate research agreement with a medical company to develop devices for cancer therapies.
The body is scheduled to consider a petition calling for a faculty-wide survey about University President Thomas LeBlanc’s performance.
Two former congresswomen and a GSPM program director examined how the congressional results of the 2020 election might impact polarization in Washington.
Kimberlé Crenshaw, the Annual Diversity Summit’s keynote speaker, addressed current social justice issues facing the people of color Thursday.